Chemical Engineering @ChemengFiles.Com

A study by researchers from the Consejo Superior de Investigaciones Científicas (CSIC) and Universidad de Murcia has found that some bacterial proteins are very similar to human proteins. Specifically, the research details the similarities between HMGA and histone H1, human protein Card and two bacteria. All of them perform functions related to
the formation of DNA and gene expression. The research is published in PNAS.

A study by researchers from the Consejo Superior de Investigaciones Científicas (CSIC) and Universidad de Murcia has found that some bacterial proteins are very similar to human proteins. Specifically, the research details the similarities between HMGA and histone H1, human protein Card and two bacteria. All of them perform functions related to
the formation of DNA and gene expression. The research is published in PNAS.

In response to requests from our participants to extend the deadline for papers and posters, the organization has extended the deadline until 24h00 on 2 October.

The First National Congress of Students and Chemical Engineering II Conference will be held in the city of Loja - Ecuador from 15 to 17 October 2008. Will be held Technical University Particular de Loja.

In response to requests from our participants to extend the deadline for papers and posters, the organization has extended the deadline until 24h00 on 2 October.

The First National Congress of Students and Chemical Engineering II Conference will be held in the city of Loja - Ecuador from 15 to 17 October 2008. Will be held Technical University Particular de Loja.

Novagali Pharma has announced that it has successfully completed a Phase II clinical study with Cyclokat (R), its formula of cyclosporine. The results show a statistically significant improvement in signs and symptoms in patients Advertisement suffering from dry eye syndrome among moderate and severe.

For this clinical trial on dry eye, Novagali worked Ora, Inc., an organization of global clinical research and development located enAndover, MA, USA This vehicle-controlled study, phase II, multicenter, randomized, double-mask of 132 patients evaluated the safety and efficacy of Cyclokat (R) applied once daily for three months. The clinical model of Controlled Adverse Environment (CAE) Ora property was used in this study in U.S.

Novagali Pharma has announced that it has successfully completed a Phase II clinical study with Cyclokat (R), its formula of cyclosporine. The results show a statistically significant improvement in signs and symptoms in patients Advertisement suffering from dry eye syndrome among moderate and severe.

For this clinical trial on dry eye, Novagali worked Ora, Inc., an organization of global clinical research and development located enAndover, MA, USA This vehicle-controlled study, phase II, multicenter, randomized, double-mask of 132 patients evaluated the safety and efficacy of Cyclokat (R) applied once daily for three months. The clinical model of Controlled Adverse Environment (CAE) Ora property was used in this study in U.S.